Figure 2.
GRK2 does not affect carrageenan- or CCL3-induced inflammatory response. a, Carrageenan-induced increase in paw thickness expressed as percentage of baseline (n = 8). b, MPO content of paw biopsies as a measure of granulocyte infiltration at 6 h, 1 d, and 7 d after carrageenan injection (n = 6 − 12). c, IL-1β mRNA in paw biopsies at 6 h after carrageenan injection. d, CCL3 mRNA in paw biopsies at 6 h after carrageenan injection (n = 7). e, IL-1β mRNA in paw biopsies at 24 h after intraplantar CCL3 injection (n = 4). f, TNF-α mRNA in paw biopsies at 24 h after CCL3 injection (n = 4). g, CCL3-induced increase in paw thickness expressed as a percentage of baseline (n = 7). h, MPO content of paw biopsies at 6 h after intraplantar CCL3 injection (n = 8 − 11). Data are expressed as mean ± SEM. **p < 0.01.